Рет қаралды 1,192
Dr Arthur Roach, Director of the Parkinson’s Virtual Biotech at Parkinson's UK, and Dr Adrian Newman-Tancredi, CEO and Co-founder of Neurolixis, discuss a pioneering partnership that has led to hopeful results from a clinical trial of NLX112.
For more information, visit www.parkinsons...